Jointown Pharmaceutical Group Co Ltd Market Cap ($3.87 Billion)
Market Cap & Net Worth: Jointown Pharmaceutical Group Co Ltd (600998)
Jointown Pharmaceutical Group Co Ltd market cap. Jointown Pharmaceutical Group Co Ltd (SHG:600998) has a market capitalization of $3.87 Billion (CN¥26.42 Billion) as of November 8, 2026. Listed on the SHG stock exchange, this China-based company holds position #4092 globally and #576 in its home market, demonstrating a 1.75% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Jointown Pharmaceutical Group Co Ltd's stock price CN¥5.24 by its total outstanding shares 5042470234 (5.04 Billion). Also see 600998 cash generation efficiency for how efficiently the company converts equity into cash flow.
Jointown Pharmaceutical Group Co Ltd Market Cap History (2015–2026)
Jointown Pharmaceutical Group Co Ltd market cap history from 2015 to 2026. Data shows change from $5.78 Billion to $3.87 Billion (-2.93% CAGR). Check 600998 live share price for real-time trading data and today's change.
Jointown Pharmaceutical Group Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Jointown Pharmaceutical Group Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Jointown Pharmaceutical Group Co Ltd (600998) equity growth momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.02x
Jointown Pharmaceutical Group Co Ltd's market cap is 0.02 times its annual revenue
Latest Price to Earnings (P/E) Ratio
1.51x
Jointown Pharmaceutical Group Co Ltd's market cap is 1.51 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $5.78 Billion | $49.59 Billion | $694.53 Million | 0.12x | 8.32x |
| 2016 | $6.18 Billion | $61.56 Billion | $876.74 Million | 0.10x | 7.05x |
| 2017 | $5.65 Billion | $73.94 Billion | $1.45 Billion | 0.08x | 3.91x |
| 2018 | $4.39 Billion | $87.14 Billion | $1.34 Billion | 0.05x | 3.27x |
| 2019 | $4.30 Billion | $99.50 Billion | $1.73 Billion | 0.04x | 2.49x |
| 2020 | $5.52 Billion | $110.86 Billion | $3.08 Billion | 0.05x | 1.79x |
| 2021 | $4.67 Billion | $122.41 Billion | $2.45 Billion | 0.04x | 1.91x |
| 2022 | $4.29 Billion | $140.42 Billion | $2.08 Billion | 0.03x | 2.06x |
| 2023 | $5.17 Billion | $150.14 Billion | $2.17 Billion | 0.03x | 2.38x |
| 2024 | $3.78 Billion | $151.81 Billion | $2.51 Billion | 0.02x | 1.51x |
Competitor Companies of 600998 by Market Capitalization
Companies near Jointown Pharmaceutical Group Co Ltd in the global market cap rankings as of November 8, 2026. Also see Jointown Pharmaceutical Group Co Ltd assets under control for a full breakdown of the balance sheet.
Key companies related to Jointown Pharmaceutical Group Co Ltd by market ranking:
- McKesson Corporation (NYSE:MCK): Ranked #245 globally with a market cap of $101.38 Billion USD.
- Cencora Inc. (NYSE:COR): Ranked #446 globally with a market cap of $61.32 Billion USD.
- Cardinal Health Inc (NYSE:CAH): Ranked #616 globally with a market cap of $43.01 Billion USD.
- Sigma Healthcare Ltd (AU:SIG): Ranked #1118 globally with a market cap of $23.03 Billion USD ( AU$32.55 Billion AUD).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #245 | McKesson Corporation | NYSE:MCK | $101.38 Billion | $1060.84 |
| #446 | Cencora Inc. | NYSE:COR | $61.32 Billion | $333.56 |
| #616 | Cardinal Health Inc | NYSE:CAH | $43.01 Billion | $271.72 |
| #1118 | Sigma Healthcare Ltd | AU:SIG | $23.03 Billion | AU$2.82 |
Market Capitalization of Jointown Pharmaceutical Group Co Ltd (2015–2026)
Market capitalization of Jointown Pharmaceutical Group Co Ltd from 2015 to today. Between 2015 and today, Jointown Pharmaceutical Group Co Ltd's market cap moved from $5.78 Billion to $ 3.87 Billion, with a yearly change of -2.93%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥3.87 Billion | +2.34% |
| 2025 | CN¥3.78 Billion | 0.00% |
| 2024 | CN¥3.78 Billion | -26.96% |
| 2023 | CN¥5.17 Billion | +20.54% |
| 2022 | CN¥4.29 Billion | -8.18% |
| 2021 | CN¥4.67 Billion | -15.30% |
| 2020 | CN¥5.52 Billion | +28.34% |
| 2019 | CN¥4.30 Billion | -1.98% |
| 2018 | CN¥4.39 Billion | -22.32% |
| 2017 | CN¥5.65 Billion | -8.63% |
| 2016 | CN¥6.18 Billion | +6.99% |
| 2015 | CN¥5.78 Billion | -- |
End of Day Market Cap According to Different Sources
On Nov 7th, 2026 the market cap of Jointown Pharmaceutical Group Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $3.87 Billion USD |
| MoneyControl | $3.87 Billion USD |
| MarketWatch | $3.87 Billion USD |
| marketcap.company | $3.87 Billion USD |
| Reuters | $3.87 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Jointown Pharmaceutical Group Co Ltd
Jointown Pharmaceutical Group Co., Ltd engages in pharmaceutical distribution and supply chain business in China and internationally. It is also involved in general agency brand promotion; pharmaceutical industrial self-production and OEM; and pharmaceutical new retail and ten-thousand store alliance plan businesses. In addition, the company provides medical health and technology value-added serv… Read more